Bifidobacterium longum subsp. infantis 157F

Gram-positiveRodNon-motileAnaerobe

Kingdom

Bacillati

Phylum

Actinomycetota

Class

Actinomycetes

Order

Bifidobacteriales

Family

Bifidobacteriaceae

Genus

Bifidobacterium

Description

Bifidobacterium longum is an anaerobic, non-halophilic, Gram-positive bacterium that is commonly found in the intestines of humans and most animals and insects. They were first isolated and described over one hundred years ago from human feces and were quickly associated with a healthy gastrointestinal tract (GIT) due to their numerical dominance in breast fed infants compared to bottle fed infants. In the neonate their numerical advantage confers a substantial health benefit by hindering pathogen colonization through competitive exclusion. It is important for establishing and maintaining homeostasis of the intestinal ecosystem to allow for normal digestion. B. longum is characterized by a unique hexose metabolism that occurs via a phosphoketolase pathway often termed the bifid shunt. Fructose-6-phosphate phosphoketolase (F6PPK) is a key enzyme of the bifid shunt and its presence is the most common diagnostic test for this genus, as it is not present in other Gram-positive intestinal bacteria. B. longum is often the dominant species detected in humans and is the only species to regularly harbor plasmids. It is a leading member of the probiotic bacteria due to numerous studies that have provided a growing body of evidence for its role in a myriad of potential health benefits. These include diarrhea prevention in antibiotic treated patients, cholesterol reduction, alleviation of lactose intolerance symptoms, immune stimulation and cancer prevention. The stabilizing effect on GIT microflora is attributed to the capacity of bifidobacterium to produce bacteriocins, which are bacteriostatic agents with a broad spectrum of action, and to their pH-reducing activity. Selection of suitable strains for probiotic purposes is very difficult as inherent characteristics of strains of B. longum that are necessary for its survival and competition in the human large intestine are currently very poorly understood. The use of the sequenced genome in microarray analysis reveals pertinent traits that are important to attain dominance in these complex ecosystems. (EBI Integr8)

Taxonomy

KingdomBacillati
PhylumActinomycetota
ClassActinomycetes
OrderBifidobacteriales
FamilyBifidobacteriaceae
GenusBifidobacterium
SpeciesBifidobacterium longum
Strain157F-NC

Profile

Physiology
Gram staining propertiesPositive
ShapeRod
MobilityNo
Flagellar presenceYes
Number of membranes1
Image of Bifidobacterium longum subsp. infantis 157F
Image source: Wikipedia/Wikimedia
Ecology, Host, and Life Cycle
Oxygen requirementsAnaerobe
Optimal temperature37
Temperature rangeMesophilic
HabitatHostAssociated
Biotic relationshipFree living
Host(s)Not Available
Cell arrangementClusters - Pairs - Singles
SporulationNonsporulating
Energy sourceNot Available
PathogenicityNo

Genome Summary

Bifidobacterium longum subsp. infantis 157F


Gene Summary

Adenine Count

1001 bp

Thymine Count

864 bp

Guanine Count

1419 bp

Cytosine Count

1611 bp

Genome Length

4895 bp

Protein-coding Genes

5 genes

Non-Coding Genes

0 genes

# of Chromosomes/Plasmids

2

Genes

NameLocus TagUniProt IDStrand OrientationGene Start/EndProtein Molecular Weight
hypothetical proteinBLIF_RS10230Not AvailableNegative1177 - 168017324.3
hypothetical proteinBLIF_RS11655Not AvailablePositive2065 - 22175475.99
hypothetical proteinBLIF_RS10235Not AvailablePositive2322 - 25407919.94
replication initiation proteinBLIF_RS10240Not AvailableNegative2591 - 350234219.7
hypothetical proteinBLIF_RS10245Not AvailableNegative3762 - 418116114.1
moba/mobl family proteinBLIF_RS10250Not AvailablePositive1 - 170164686.8
replication initiation proteinBLIF_RS10255Not AvailableNegative1698 - 259733974.6
hypothetical proteinBLIF_RS10260Not AvailableNegative2826 - 333819426.5

Displaying genes 1 – 8 of 8 in total

Pathways

0 pathways

No pathways found

No metabolic pathways have been associated with this bacterium yet.

Metabolites

295 records
Metabolite IDMetabolite nameStructureCAS number
BASm0000237(R)-4'-phosphopantothenateC9H18NO8PChemical structure of (R)-4'-phosphopantothenateNot available
Average299.2149Da
Monoisotopic299.0770031Da
BASm00002512-dehydropantoateC6H9O4Chemical structure of 2-dehydropantoateNot available
Average145.1333Da
Monoisotopic145.050083776Da
BASm0000377(S)-malateC4H4O5Chemical structure of (S)-malateNot available
Average132.0716Da
Monoisotopic132.005873238Da
BASm0000989GlycerolC3H8O3Chemical structure of Glycerol56-81-5
Average92.0938Da
Monoisotopic92.04734412Da
BASm0001035indole-3-pyruvateC11H8NO3Chemical structure of indole-3-pyruvate35656-49-6
Average202.1861Da
Monoisotopic202.0504181Da
BASm0001167triphosphateO10P3Chemical structure of triphosphate14127-68-5
Average252.9153Da
Monoisotopic252.8704308Da
BASm00011795-hydroxyisourateC5H4N4O4Chemical structure of 5-hydroxyisourateNot available
Average184.1097Da
Monoisotopic184.0232546Da
BASm0001661Cu(2+)CuChemical structure of Cu(2+)7440-50-8
Average63.546Da
Monoisotopic62.929601079Da
BASm0001921(S)-3-methyl-2-oxopentanoateC6H9O3Chemical structure of (S)-3-methyl-2-oxopentanoate1460-34-0
Average129.1339Da
Monoisotopic129.0551692Da
BASm00022412-demethylmenaquinone-8C50H70O2Chemical structure of 2-demethylmenaquinone-8Not available
Average703.0896Da
Monoisotopic702.5375815Da

Displaying 1–10 of 295 metabolites

Health Effects

No health effects information available for this bacterium.